Coacervate Cytokine Delivery System for Localized Sustained Release
Solution Overview
Problem
Current methods for delivering cytokines, such as interleukins and interferons, suffer from systemic toxicities and lack controlled release mechanisms, making them ineffective and unsafe for treating conditions like coronary heart disease and cancer.
Innovation Solution
A controlled delivery system using a coacervate composed of a polycationic polymer, a polyanionic polymer like heparin, and a cytokine, which forms spherical droplets for sustained release over days to months, reducing systemic toxicity and improving treatment efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cytokines are delivered systemically to treat cancer and coronary heart disease, then treatment efficacy is improved, but systemic toxicities increase and can even cause patient deaths
Solution Approach 1:
The patent applies local quality by transitioning from systemic cytokine delivery to localized delivery at the treatment site. The coacervate formulation enables site-specific release of cytokines directly at the tumor or cardiac tissue, maintaining therapeutic efficacy while avoiding distribution to healthy organs and tissues, thereby reducing systemic toxicities
Solution Approach 2:
The patent uses the coacervate system as an intermediary carrier between the cytokine and the target tissue. This intermediary enables controlled local delivery, preventing direct systemic circulation of cytokines while still achieving therapeutic concentrations at the disease site through localized administration
2Ease of operation
If cytokines are delivered using conventional vehicles like saline, then delivery is simple, but release is uncontrolled and occurs as a large bolus causing toxicity
Solution Approach 1:
The patent changes the physical and chemical parameters of the delivery system by using coacervates with specific viscosities and gelation properties. The coacervate's unique rheological characteristics enable sustained release kinetics, transforming the delivery profile from rapid bolus injection to controlled prolonged release while maintaining ease of administration through injection
3Reliability
If high-doses of cytokines are administered over prolonged periods, then treatment efficacy is improved, but severe toxicities and patient deaths occur
Solution Approach 1:
The patent implements local quality by concentrating cytokine delivery at the disease site rather than distributing it systemically. This localized approach allows for effective dosing at the target tissue without exposing other organs to toxic levels, enabling prolonged treatment without severe systemic toxicities
Solution Approach 2:
The patent achieves continuity of useful action through sustained release of cytokines from the coacervate over days to months. This continuous local delivery maintains therapeutic efficacy without requiring repeated high-dose systemic administrations that cause severe toxicities
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The coacervate system enables safe and effective localized delivery of cytokines, enhancing treatment outcomes for coronary heart disease and cancer by providing sustained release and reduced toxicity, improving cardiac function and tumor response.
Implementation Method 1
Complex coacervates are formed by mixing oppositely charged polyelectrolytes resulting in spherical droplets of organic molecules held together noncovalently
Data Source
AI summary
Provided herein are coacervate compositions including cytokines, and methods of making and using the same. The coacervate can be formed by the mixing of an active agent, such as a drug or protein with the polyanion, such as heparin or heparan sulfate, and a custom-made polycation (e.g., PEAD or PELD). The coacervates can be used in the treatment of diseases and disorders where targeted treatment is desired, for example in treatment of cancers.